The Board of Directors of Sword & Shield Pharma Limited at its meeting held on April 26, 2017, has proposed the Amalgamation in the nature of Merger of Praveg Communications Limited ("the Transferor Company" or "PCL") with Sword & Shield Pharma Limited ("the Transferee Company" or "SSPL" or "the Company"), under Sections 230 to 232 of the Companies Act, 2013 and other applicable laws including the provisions of the Companies Act, 1956 to the extent applicable with the appointed date i.e. April 01, 2016. The same is subject to the approval of the Shareholders, the National Company Law Tribunal, Ahmedabad (NCLT) and all the other regulatory approvals.
Shares of SWORD & SHIELD PHARMA LTD. was last trading in BSE at Rs.5.27 as compared to the previous close of Rs. 5.03. The total number of shares traded during the day was 4744 in over 14 trades.
The stock hit an intraday high of Rs. 5.27 and intraday low of 4.78. The net turnover during the day was Rs. 24273.